Aspirin has been eliminated as a possible treatment for patients hospitalised with Covid-19. This follows a large randomised clinical trial in the UK that assessed the effects of the compound on the survival of Covid-19 patients and their risk of developing a rare type of blood clot. Aspirin is widely used to reduce blood clotting in other diseases.
